Scholarlink

Background <p>Canine parvovirus (CPV) continues to be a predominant cause of morbidity and mortality among dogs worldwide. In Ghana, data on clinical predictors, service type (inpatient or outpatient), and clinical outcomes in dogs afflicted by CPV is limited. This cross-sectional study, conducted at a Veterinary Teaching Hospital in Kumasi, Ghana, assessed the clinical factors associated with CPV diagnosis, service delivery types, and clinical outcomes in dogs. Diagnosis was based on compatible clinical signs and results from a Vcheck CPV antigen test kit with the V200 analyser (Bionote Inc., Korea), with dogs classified as CPV-positive or CPV-negative based on test results. Demographics, vaccination status, clinical signs, service type, and outcome data were recorded. Odds ratios were reported with 95% confidence intervals, and a significance threshold of <i>p</i> &lt; 0.05 was set for regression analyses.</p> Results <p>A total of 129 CPV-positive dogs were diagnosed, with an overall mortality rate of 26.4% (34/129), compared to 8.5% (7/82) among CPV-negative dogs. Haemorrhagic diarrhoea (OR = 6.84), vomiting (OR = 2.75), lower body weight (OR = 0.94 per kg increase), and complete loss of appetite (OR = 4.29) were significant independent predictors of CPV infection. CPV-positive dogs were significantly more likely to require inpatient care than CPV-negative dogs (OR = 7.57, <i>p</i> &lt; 0.001).</p> Conclusions <p>CPV has a significant impact on dog morbidity and mortality in Ghana, with important emotional and financial consequences for affected dog owners. Classic gastrointestinal signs may assist in the clinical assessment of suspected cases in practice. CPV-positive dogs had higher inpatient care rates and mortality compared to CPV-negative dogs. These findings emphasise the need for improved vaccination uptake, client education, and clinical management practices to reduce CPV-related mortality in affected populations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical factors, service type, and clinical outcomes associated with canine parvovirus in dogs presented at the KNUST Veterinary Teaching Hospital in Kumasi, Ghana

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月18日

查看全文
  • Jemima Dzigbordi Agbota,
  • Raphael Deladem Folitse,
  • Emmanuel Darko Opoku,
  • Dorcas Oyueley Kodie,
  • William Tasiame,
  • Benjamin Obukowho Emikpe

摘要

Background

Canine parvovirus (CPV) continues to be a predominant cause of morbidity and mortality among dogs worldwide. In Ghana, data on clinical predictors, service type (inpatient or outpatient), and clinical outcomes in dogs afflicted by CPV is limited. This cross-sectional study, conducted at a Veterinary Teaching Hospital in Kumasi, Ghana, assessed the clinical factors associated with CPV diagnosis, service delivery types, and clinical outcomes in dogs. Diagnosis was based on compatible clinical signs and results from a Vcheck CPV antigen test kit with the V200 analyser (Bionote Inc., Korea), with dogs classified as CPV-positive or CPV-negative based on test results. Demographics, vaccination status, clinical signs, service type, and outcome data were recorded. Odds ratios were reported with 95% confidence intervals, and a significance threshold of p < 0.05 was set for regression analyses.

Results

A total of 129 CPV-positive dogs were diagnosed, with an overall mortality rate of 26.4% (34/129), compared to 8.5% (7/82) among CPV-negative dogs. Haemorrhagic diarrhoea (OR = 6.84), vomiting (OR = 2.75), lower body weight (OR = 0.94 per kg increase), and complete loss of appetite (OR = 4.29) were significant independent predictors of CPV infection. CPV-positive dogs were significantly more likely to require inpatient care than CPV-negative dogs (OR = 7.57, p < 0.001).

Conclusions

CPV has a significant impact on dog morbidity and mortality in Ghana, with important emotional and financial consequences for affected dog owners. Classic gastrointestinal signs may assist in the clinical assessment of suspected cases in practice. CPV-positive dogs had higher inpatient care rates and mortality compared to CPV-negative dogs. These findings emphasise the need for improved vaccination uptake, client education, and clinical management practices to reduce CPV-related mortality in affected populations.